ANIK logo

Anika Therapeutics (ANIK)

Profile

Full Name

Anika Therapeutics, Inc.

Ticker Symbol

ANIK

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

May 3, 1993

Indexes

Not included

Website

http://www.anika.com

Employees

288

Key Details

Price

$13.72(-1.22%)

Market cap

$194.49M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$119.91M(-0.73% YoY)

Annual EPS

-$3.83(+32.09% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$13.72
ANIK price is $13.72

30-Day Relative Volume

0.63
ANIK 30-day relative volume is 0.63

Price Performance

Price Today change

-1.22%
ANIK price is down -1.22% today

Price YTD change

-16.65%
ANIK price is down -16.65% since January 1st

Price 1-year change

-45.79%
ANIK price is down -45.79% year-on-year

Price 3-year change

-40.84%
ANIK price is down -40.84% over the past 3 years

Price Range

Price All-time high

$75.72
ANIK price is currently -81.88% below its historical high of $75.72

Price 3-year low

$12.83
ANIK price is currently +6.94% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$194.49M
ANIK market capitalization is $194.49 million

Market cap 3-year change

-42.24%
ANIK market capitalization is down -42.24% over the past 3 years

Market cap All-time high

$1.05B
ANIK market capitalization is currently -81.42% below its historical high of $1.05 billion

Market cap sector rank

56.83%
ANIK market capitalization is higher than 56.83% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-4.35%
ANIK shares outstanding is down -4.35% year-on-year

Shares Outstanding 3-Year Change

-2.36%
ANIK shares outstanding is down -2.36% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.78
ANIK beta is 0.78

200-day SMA

$20.50
ANIK price is currently -33.07% below its 200-day simple moving average

50-day SMA

$16.20
ANIK price is currently -15.32% below its 50-day simple moving average

RSI

34.78
ANIK 14-day relative strength index is 34.78

Volume

0.63
ANIK 30-day relative volume is 0.63

ATR

$0.81
ANIK average true range is $0.81

10-day Historical Volatility

53.47%
ANIK 10-day historical volatility is 53.47%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$119.91M
ANIK annual revenue is $119.91 million

Revenue Analysts estimate

$112.50M
ANIK annual revenue is currently +6.58% higher than the consensus analysts' forecast

Revenue 1-year change

-0.73%
ANIK annual revenue is down -0.73% year-on-year

Revenue Sector rank

58.01%
ANIK annual revenue is higher than 58.01% of companies in Healthcare sector

EPS

EPS

-$3.83
ANIK annual earnings per share is -$3.83

EPS Analysts estimate

$0.31
ANIK annual earnings per share is currently -1335.48% lower than the consensus analysts' forecast

EPS 1-year change

+32.09%
ANIK annual earnings per share is up +32.09% year-on-year

EPS Sector rank

23.82%
ANIK annual earnings per share is higher than 23.82% of companies in Healthcare sector

Profit

Gross profit

$76.00M
ANIK annual gross profit is $76.00 million

Gross margin

63.38%
ANIK annual gross profit margin is 63.38%

Operating profit

-$5.10M
ANIK annual operating income is -$5.10 million

Operating margin

-4.25%
ANIK annual operating profit margin is -4.25%

Net income

-$56.38M
ANIK annual net profit is -$56.38 million

Net margin

-47.02%
ANIK annual net profit margin is -47.02%

Expenses

Total expenses

$125.01M
ANIK annual total expenses is $125.01 million

Operating expenses

$81.10M
ANIK annual total operating expenses is $81.10 million

Cost of goods sold

$43.91M
ANIK annual cost of goods sold is $43.91 million

Selling, general & administrative expenses

$55.55M
ANIK annual SGA is $55.55 million

Depreciation and amortization

$8.12M
ANIK annual depreciation & amortization is $8.12 million

Interest expense

-
ANIK annual interest expense value is unknown

Income tax

$6.06M
ANIK annual income tax is $6.06 million

EBIT & EBITDA

EBIT

-$5.10M
ANIK annual earnings before interest & taxes is -$5.10 million

EBITDA

-$5.10M
ANIK annual EBITDA is -$5.10 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$202.74M
ANIK annual total assets is $202.74 million

Non current assets

$89.09M
ANIK annual long term assets is $89.09 million

Current assets

$113.65M
ANIK annual total current assets is $113.65 million

Cash and cash equivalents

$55.63M
ANIK annual cash & cash equivalents is $55.63 million

Accounts receivable

$23.59M
ANIK annual accounts receivable is $23.59 million

Inventory

$23.81M
ANIK annual inventory is $23.81 million

Liabilities

Total liabilities

$48.75M
ANIK annual total liabilities is $48.75 million

Long term liabilities

$25.45M
ANIK annual total long term liabilities is $25.45 million

Current liabilities

$23.31M
ANIK annual total current liabilities is $23.31 million

Accounts payable

$5.62M
ANIK annual accounts payable is $5.62 million

Debt

Total debt

$25.93M
ANIK annual total debt is $25.93 million

Total debt 1-year change

-6.52%
ANIK annual total debt is down -6.52% year-on-year

Long term debt

$24.01M
ANIK annual long term debt is $24.01 million

Short term debt

$1.92M
ANIK annual short term debt is $1.92 million

Equity & Capital

Shareholders equity

$153.99M
ANIK annual stockholders equity is $153.99 million

Book value

$153.99M
ANIK annual book value is $153.99 million

Retained earnings

$71.67M
ANIK annual retained earnings is $71.67 million

Working capital

$90.35M
ANIK annual working capital is $90.35 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$5.40M
ANIK annual cash flow from operations is $5.40 million

Cash from operations 1-year change

+402.18%
ANIK annual cash flow from operations is up +402.18% year-on-year

Cash from investing

-$8.33M
ANIK annual cash flow from investing activities is -$8.33 million

Cash from investing 1-year change

-53.57%
ANIK annual cash flow from investing activities is down -53.57% year-on-year

Cash from financing

-$12.73M
ANIK annual cash flow from financing activities is -$12.73 million

Cash from financing 1-year change

-101.28%
ANIK annual cash flow from financing activities is down -101.28% year-on-year

CAPEX

CAPEX

$8.33M
ANIK annual capital expenditures is $8.33 million

CAPEX 1-year change

+53.57%
ANIK annual capital expenditures is up +53.57% year-on-year

Free Cash Flow

Free cash flow

-$2.93M
ANIK annual free cash flow is -$2.93 million

Free cash flow 1-year change

+59.38%
ANIK annual free cash flow is up +59.38% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

63.38%
ANIK annual gross profit margin is 63.38%

Operating margin

-4.25%
ANIK annual operating profit margin is -4.25%

Net margin

-47.02%
ANIK annual net profit margin is -47.02%

ROA & ROE

ROA

-23.82%
ANIK annual return on assets is -23.82%

ROE

-30.79%
ANIK annual return on equity is -30.79%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ANIK price to earnings ratio value is unknown

PE ratio Sector rank

-
ANIK price to earnings ratio is unknown

PB Ratio

PB ratio

1.26
ANIK price to book ratio is 1.26

PB ratio Sector rank

50.12%
ANIK price to book ratio is higher than 50.12% of companies in Healthcare sector

PS Ratio

PS ratio

1.62
ANIK price to sales ratio is 1.62

PS ratio Sector rank

38.08%
ANIK price to sales ratio is higher than 38.08% of companies in Healthcare sector

Enterprise value

Enterprise value

$164.80M
ANIK enterprise value is $164.80 million

Enterprise value Sector rank

55.79%
ANIK enterprise value is higher than 55.79% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-6.81
ANIK EV/EBITDA is -6.81

EV/EBITDA Sector rank

15.22%
ANIK EV/EBITDA is higher than 15.22% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.88
ANIK annual current ratio is 4.88

Quick ratio

3.85
ANIK annual quick ratio is 3.85

Leverage

Debt to equity

0.00
ANIK annual debt to equity ratio is 0.00

Interest coverage ratio

-
ANIK annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

4
ANIK piotroski f-score is 4

Altman Z-Score

3.93
ANIK altman z-score is 3.93

Analyst ratings

Recent major analysts updates

Mar 13, 25 Barrington Research
Outperform
Nov 1, 24 Barrington Research
Outperform
Oct 22, 24 Barrington Research
Outperform
Aug 9, 24 Barrington Research
Outperform
May 29, 24 Stephens & Co.
Equal-Weight
May 9, 24 Barrington Research
Outperform
Mar 14, 24 Stephens & Co.
Equal-Weight
Mar 14, 24 Barrington Research
Outperform
Jan 3, 24 Barrington Research
Outperform
Nov 3, 23 Barrington Research
Outperform

Institutional Ownership

Similar stocks

ELMD logo
Electromed (ELMD)
AMRN logo
Amarin (AMRN)
ESPR logo
Esperion Therapeutics (ESPR)
OCGN logo
Ocugen (OCGN)
OM logo
Outset Medical (OM)
INGN logo
Inogen (INGN)
FHTX logo
Foghorn Therapeutics (FHTX)
PDEX logo
Pro-Dex (PDEX)
SOPH logo
SOPHiA GENETICS SA (SOPH)
  • What is the ticker symbol for Anika Therapeutics?
  • Does Anika Therapeutics pay dividends?
  • What sector is Anika Therapeutics in?
  • What industry is Anika Therapeutics in?
  • What country is Anika Therapeutics based in?
  • When did Anika Therapeutics go public?
  • Is Anika Therapeutics in the S&P 500?
  • Is Anika Therapeutics in the NASDAQ 100?
  • Is Anika Therapeutics in the Dow Jones?
  • When was Anika Therapeutics's last earnings report?
  • When does Anika Therapeutics report earnings?
  • Should I buy Anika Therapeutics stock now?

What is the ticker symbol for Anika Therapeutics?

The ticker symbol for Anika Therapeutics is NASDAQ:ANIK

Does Anika Therapeutics pay dividends?

No, Anika Therapeutics does not pay dividends

What sector is Anika Therapeutics in?

Anika Therapeutics is in the Healthcare sector

What industry is Anika Therapeutics in?

Anika Therapeutics is in the Drug Manufacturers - Specialty & Generic industry

What country is Anika Therapeutics based in?

Anika Therapeutics is headquartered in United States

When did Anika Therapeutics go public?

Anika Therapeutics's initial public offering (IPO) was on May 3, 1993

Is Anika Therapeutics in the S&P 500?

No, Anika Therapeutics is not included in the S&P 500 index

Is Anika Therapeutics in the NASDAQ 100?

No, Anika Therapeutics is not included in the NASDAQ 100 index

Is Anika Therapeutics in the Dow Jones?

No, Anika Therapeutics is not included in the Dow Jones index

When was Anika Therapeutics's last earnings report?

Anika Therapeutics's most recent earnings report was on Mar 12, 2025

When does Anika Therapeutics report earnings?

The next expected earnings date for Anika Therapeutics is May 8, 2025

Should I buy Anika Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page